| Literature DB >> 26150579 |
David G Pfister1, Sharon Spencer1, David M Brizel1, Barbara Burtness1, Paul M Busse1, Jimmy J Caudell1, Anthony J Cmelak1, A Dimitrios Colevas1, Frank Dunphy1, David W Eisele1, Robert L Foote1, Jill Gilbert1, Maura L Gillison1, Robert I Haddad1, Bruce H Haughey1, Wesley L Hicks1, Ying J Hitchcock1, Antonio Jimeno1, Merrill S Kies1, William M Lydiatt1, Ellie Maghami1, Thomas McCaffrey1, Loren K Mell1, Bharat B Mittal1, Harlan A Pinto1, John A Ridge1, Cristina P Rodriguez1, Sandeep Samant1, Jatin P Shah1, Randal S Weber1, Gregory T Wolf1, Frank Worden1, Sue S Yom1, Nicole McMillian1, Miranda Hughes1.
Abstract
These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Head and Neck (H&N) Cancers. These Insights describe the different types of particle therapy that may be used to treat H&N cancers, in contrast to traditional radiation therapy (RT) with photons (x-ray). Research is ongoing regarding the different types of particle therapy, including protons and carbon ions, with the goals of reducing the long-term side effects from RT and improving the therapeutic index. For the 2015 update, the NCCN H&N Cancers Panel agreed to delete recommendations for neutron therapy for salivary gland cancers, because of its limited availability, which has decreased over the past 2 decades; the small number of patients in the United States who currently receive this treatment; and concerns that the toxicity of neutron therapy may offset potential disease control advantages.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26150579 PMCID： PMC4976490 DOI： 10.6004/jnccn.2015.0102
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908